KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Net Cash Flow (2017 - 2025)

Johnson & Johnson's Net Cash Flow history spans 17 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 66.34% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached -$4.6 billion, down 281.34%, while the annual FY2025 figure was -$4.6 billion, 281.34% down from the prior year.
  • Net Cash Flow for Q4 2025 was $1.5 billion at Johnson & Johnson, up from -$300.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $14.3 billion in Q1 2025 and bottomed at -$20.1 billion in Q2 2025.
  • The 5-year median for Net Cash Flow is -$405.0 million (2024), against an average of -$195.0 million.
  • The largest annual shift saw Net Cash Flow skyrocketed 414.6% in 2023 before it plummeted 3831.57% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $3.4 billion in 2021, then plummeted by 220.1% to -$4.0 billion in 2022, then skyrocketed by 149.65% to $2.0 billion in 2023, then surged by 115.5% to $4.3 billion in 2024, then tumbled by 66.34% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Net Cash Flow are $1.5 billion (Q4 2025), -$300.0 million (Q3 2025), and -$20.1 billion (Q2 2025).